Market Cap : 120.79 M | Enterprise Value : 85.49 M | PE Ratio : At Loss | PB Ratio : 1.73 |
---|
NAS:STIM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:STIM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Neuronetics's current ratio for the quarter that ended in Jun. 2022 was 5.02.
Neuronetics has a current ratio of 5.02. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Neuronetics's Current Ratio or its related term are showing as below:
During the past 6 years, Neuronetics's highest Current Ratio was 12.74. The lowest was 1.42. And the median was 4.89.
The historical data trend for Neuronetics's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Neuronetics's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Neuronetics's Current Ratio distribution charts can be found below:
* The bar in red indicates where Neuronetics's Current Ratio falls into.
The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.
Neuronetics's Current Ratio for the fiscal year that ended in Dec. 2021
Neuronetics's Current Ratio for the quarter that ended in Jun. 2022 is calculated as * For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
Current Ratio (A: Dec. 2021 ) = Total Current Assets (A: Dec. 2021 ) / Total Current Liabilities (A: Dec. 2021 )
= 115.331 / 15.703
= 7.34
Current Ratio (Q: Jun. 2022 ) = Total Current Assets (Q: Jun. 2022 ) / Total Current Liabilities (Q: Jun. 2022 )
= 95.084 / 18.937
= 5.02
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Thank you for viewing the detailed overview of Neuronetics's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Cannell Capital Llc | 10 percent owner | 245 MERIWETHER CIRCLE ALTA WY 83414 |
Rosengarten Megan | director | C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Cascella Robert | director | C/O HOLOGIC, INC. BEDFORD MA 01730 |
Shook Bruce Joseph | director | 162 CRICKET AVE ARDMORE PA 19003 |
Jaeger Wilfred E | director | C/O THREE ARCH PARTNERS 3200 ALPINE RD PORTOLA VALLEY CA 94028 |
Bakewell John K | director | C/O LANTHEUS MEDICAL IMAGING, INC. 331 TREBLE COVE ROAD NO. BILLERICA MA 01862 |
Conley Sheryl L | director | C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Muir Glenn P | director | C/O HOLOGIC, INC. BEDFORD MA 01730 |
Sullivan Keith J | director, officer: President and CEO | C/O RELIANT TECHNOLOGIES, INC. 464 ELLIS STREET MOUNTAIN VIEW CA 94043 |
Macan William Andrew | officer: Sr. VP, GC, CCO and Secretary | 24275 KATY FREEWAY, SUITE 600 KATY TX 77494 |
Harper Gregory | officer: VP of Prod. Dev. & Operations | C/O NEURONETICS, INC 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Furlong Stephen | officer: CFO | C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Tropsha Yelena | officer: VP of Commercial Access | C/O NEURONETICS, INC 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Farley Brian E | director | 2200 ZANKER ROAD SUITE F SAN JOSE CA 95131 |
Guthrie Daniel | officer: Chief Commercial Officer | C/O NEURONETICS, INC 322 PHOENIXVILLE PIKE MALVERN PA 19355 |
From GuruFocus
Other Sources
By Zacks 2022-03-09
By Fool 2021-05-04
By Zacks 2020-08-04
By Zacks 2022-03-08
By Seekingalpha 2020-11-03
By Zacks 2021-01-11
By Zacks 2022-03-10
By Zacks 2021-08-06
By Zacks 2021-08-03
By Seekingalpha 2021-03-02